Production (Stage)
D
aTyr Pharma, Inc. ATYR
$3.75 -$0.05-1.32% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -63.41M -64.02M -63.82M -57.90M -53.93M
Total Depreciation and Amortization 1.15M 1.54M 1.95M 2.55M 2.76M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.00M 282.00K -162.00K -618.00K -851.00K
Change in Net Operating Assets -903.00K -6.92M -5.02M -7.49M -2.99M
Cash from Operations -62.16M -69.12M -67.05M -63.45M -55.01M
Capital Expenditure -48.00K -65.00K -57.00K -599.00K -2.99M
Sale of Property, Plant, and Equipment 7.00K 7.00K 0.00 0.00 15.00K
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 14.21M 17.29M 41.19M 28.17M 19.66M
Cash from Investing 14.17M 17.23M 41.14M 27.57M 16.69M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -507.00K -497.00K -484.00K -467.00K -449.00K
Issuance of Common Stock 51.27M 40.36M 27.54M 30.31M 24.91M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 50.76M 39.86M 27.06M 29.85M 24.46M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 2.77M -12.02M 1.15M -6.03M -13.86M